HNRNP A3 related peptides and use thereof for diagnosis of rheumatoid arthritis

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8597955
APP PUB NO 20120070854A1
SERIAL NO

13141960

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to a peptide and retro or retro-inverso peptide thereof, with a length of ≦25 amino acid residues, characterized in that the peptide comprises at least one citrulline residue, and exhibits a sequence identity over the whole sequence of the peptide of ≧70% compared to human hnRNP A3 protein (SEQ ID No. 1) and uses thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • CHARITE-UNIVERSITAETSMEDIZIN BERLIN;CHARITE—UNIVERSITATSMEDIZIN BERLIN

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Adolph, Kerstin Gau-Algesheim, DE 1 0
Hollidt, Jørg Berlin, DE 1 0
Skriner, Karl Berlin, DE 12 4

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 3, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00